125 related articles for article (PubMed ID: 31393884)
1. Pilot feasibility study of a semi-automated three-dimensional scoring system for cervical dystonia.
Nakamura T; Sekimoto S; Oyama G; Shimo Y; Hattori N; Kajimoto H
PLoS One; 2019; 14(8):e0219758. PubMed ID: 31393884
[TBL] [Abstract][Full Text] [Related]
2. [Inter-rater reliability while using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in patients with cervical dystonia].
Kaji R; Osawa M; Yanagisawa N
Brain Nerve; 2009 Jan; 61(1):65-71. PubMed ID: 19177808
[TBL] [Abstract][Full Text] [Related]
3. Pilot Feasibility Study of a Multi-View Vision Based Scoring Method for Cervical Dystonia.
Ye C; Xiao Y; Li R; Gu H; Wang X; Lu T; Jin L
Sensors (Basel); 2022 Jun; 22(12):. PubMed ID: 35746424
[TBL] [Abstract][Full Text] [Related]
4. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale.
Comella CL; Stebbins GT; Goetz CG; Chmura TA; Bressman SB; Lang AE
Mov Disord; 1997 Jul; 12(4):570-5. PubMed ID: 9251076
[TBL] [Abstract][Full Text] [Related]
5. Reliability, feasibility and satisfaction of telemedicine evaluations for cervical dystonia.
Fraint A; Stebbins GT; Pal G; Comella CL
J Telemed Telecare; 2020 Oct; 26(9):560-567. PubMed ID: 31208263
[TBL] [Abstract][Full Text] [Related]
6. The Toronto Western Spasmodic Torticollis Rating Scale: reliability in neurologists and physiotherapists.
Boyce MJ; Canning CG; Mahant N; Morris J; Latimer J; Fung VS
Parkinsonism Relat Disord; 2012 Jun; 18(5):635-7. PubMed ID: 22405838
[TBL] [Abstract][Full Text] [Related]
7. Assessing the burden of illness from cervical dystonia using the Toronto Western Spasmodic Torticollis Rating Scale scores and health utility: a meta-analysis of baseline patient-level clinical trial data.
Jen MH; Kurth H; Iheanacho I; Dinet J; Gabriel S; Wasiak R; Jost WH
J Med Econ; 2014 Nov; 17(11):803-9. PubMed ID: 25155368
[TBL] [Abstract][Full Text] [Related]
8. Clinimetric testing of the comprehensive cervical dystonia rating scale.
Comella CL; Perlmutter JS; Jinnah HA; Waliczek TA; Rosen AR; Galpern WR; Adler CA; Barbano RL; Factor SA; Goetz CG; Jankovic J; Reich SG; Rodriguez RL; Severt WL; Zurowski M; Fox SH; Stebbins GT
Mov Disord; 2016 Apr; 31(4):563-9. PubMed ID: 26971359
[TBL] [Abstract][Full Text] [Related]
9. Minimal clinically important change in the Toronto Western Spasmodic Torticollis Rating Scale.
Espay AJ; Trosch R; Suarez G; Johnson J; Marchese D; Comella C
Parkinsonism Relat Disord; 2018 Jul; 52():94-97. PubMed ID: 29530726
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.
Tarsy D
Mov Disord; 1997 Jan; 12(1):100-2. PubMed ID: 8990061
[TBL] [Abstract][Full Text] [Related]
11. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
Samotus O; Lee J; Jog M
J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
[TBL] [Abstract][Full Text] [Related]
12. Clinical and goniometric evaluation of patients with spasmodic torticollis.
Salvia P; Champagne O; Feipel V; Rooze M; de Beyl DZ
Clin Biomech (Bristol, Avon); 2006 May; 21(4):323-9. PubMed ID: 16427167
[TBL] [Abstract][Full Text] [Related]
13. Cervical dystonia severity scale reliability study.
O'Brien C; Brashear A; Cullis P; Truong D; Molho E; Jenkins S; Wojcieszek J; O'Neil T; Factor S; Seeberger L
Mov Disord; 2001 Nov; 16(6):1086-90. PubMed ID: 11748739
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia.
Münchau A; Palmer JD; Dressler D; O'Sullivan JD; Tsang KL; Jahanshahi M; Quinn NP; Lees AJ; Bhatia KP
Brain; 2001 Apr; 124(Pt 4):769-83. PubMed ID: 11287376
[TBL] [Abstract][Full Text] [Related]
15. Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study.
Dashtipour K; Mari Z; Jankovic J; Adler CH; Schwartz M; Brin MF
J Neurol Sci; 2019 Oct; 405():116413. PubMed ID: 31494402
[TBL] [Abstract][Full Text] [Related]
16. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
Dressler D; Kupsch A; Seitzinger A; Paus S
Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
[TBL] [Abstract][Full Text] [Related]
17. Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology.
Comella CL; Fox SH; Bhatia KP; Perlmutter JS; Jinnah HA; Zurowski M; McDonald WM; Marsh L; Rosen AR; Waliczek T; Wright LJ; Galpern WR; Stebbins GT
Mov Disord Clin Pract; 2015 Jun; 2(2):135-141. PubMed ID: 27088112
[TBL] [Abstract][Full Text] [Related]
18. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
19. Active exercise for individuals with cervical dystonia: a pilot randomized controlled trial.
Boyce MJ; Canning CG; Mahant N; Morris J; Latimer J; Fung VS
Clin Rehabil; 2013 Mar; 27(3):226-35. PubMed ID: 22904115
[TBL] [Abstract][Full Text] [Related]
20. Deep Brain Stimulation Versus Peripheral Denervation for Cervical Dystonia: A Systematic Review and Meta-Analysis.
Ravindran K; Ganesh Kumar N; Englot DJ; Wilson TJ; Zuckerman SL
World Neurosurg; 2019 Feb; 122():e940-e946. PubMed ID: 30419402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
